Survival rates for lung cancer patients in the UK are ‘severely lagging behind Europe’

PATIENTS diagnosed with lung cancer in the UK face survival rates that are "lagging" behind other parts of Europe, experts today warned.

The UK Lung Cancer Coalition, which is made up of various lung charities and sponsored by the pharmaceutical industry, has called for a "drastic improvement" in lung cancer care to drive up survival rates.

A poll of 150 lung specialists, presented in a new report by the Coalition, found that two thirds believed that the most important factor for improving five-year survival rates was ensuring patients received an early diagnosis.

But a separate survey of 100 lung cancer patients or their carers found that 36 per cent waited more than a month for a definitive diagnosis - and 17 per cent waited more than two months.

Meanwhile, 43 per cent of patients said they waited for more than a month for the initiation of treatment after a diagnosis was confirmed.

Lung cancer has been the UK's biggest cancer killer for the past decade, the report states.

It adds that lung cancer has one of the lowest survival outcomes of any cancer type.

The Coalition has challenged governments across England, Wales, Scotland and Northern Ireland to increase five year survival rates to 25 per cent by 2025.

In England just 16 per cent of patients who are diagnosed with lung cancer are alive five years after diagnosis, the report states.

Just 9.8 per cent of Scots diagnosed with lung cancer live for five years and 6.6 per cent of Welsh patients survive for five years, it adds.

In Northern Ireland, 10.5 per cent of patients are alive five years after diagnosis, according to the document.

Lung cancer survival rates across the UK still lag severely behind our European counterparts and compare poorly with other major common cancer types

Professor Mick Peake

The report authors make a series of recommendations on how to improve survival rates including an audit of cancer waiting times.

"The highest five-year survival rate across the UK is currently predicted to be 16 per cent in patients diagnosed in 2013 in England, which is effectively double what it was in 2005 when the UKLCC was established," said Professor Mick Peake, chairman of the Coalition's clinical advisory group.

"However, we cannot be complacent. Lung cancer survival rates across the UK still lag severely behind our European counterparts and compare poorly with other major common cancer types."